by Marie Kelly | Mar 30, 2020 | COVID-19, Health, Healthcare
“The coronavirus outbreak is wreaking havoc on the global economy. The Chinese economy is being adversely hampered, with other economies across the globe facing severe negative effects as well. Frost & Sullivan has analysed the outlook for three scenarios, the...
by Jennifer McCormack | Mar 12, 2020 | Connected Health, Health, Healthcare, Medtech, Medtech, Pharma/Bio
“The global orphan drugs market should reach $315.6 billion by 2024 from $127.5 billion in 2017 at a compound annual growth rate (CAGR) of 13.8% for the forecast period of 2017 to 2024.” BCC Research – ROI in Pharmaceutical R&D: How to Halt the Decline BCC...
by Darren Kelly | Feb 20, 2020 | Connected Health, Health, Wellbeing, Wellness
“50% of consumers struggling with high or extreme stress are currently looking for new treatment solutions. Companies and brands creating sleep aids and stress relief products should ensure that they highlight and focus on quality of sleep when creating and marketing...
by Darren Kelly | Jan 24, 2020 | Healthcare, Pharma/Bio
“At present, neurodegenerative diseases represent one of the main causes of death in the industrialized economy. Overall characterized by a loss of neurons in particular regions of the nervous system, the subsequent decline in cognitive and motor function that...
by Darren Kelly | Jan 16, 2020 | Healthcare, Pharma/Bio
The global enterprise imaging market is estimated at $933.7 million in 2018. The market is picking up pace in developed countries and other major geographies that have high penetration of radiology and cardiology PACS, enterprise-level VNA and electronic health...
by Darren Kelly | Jan 9, 2020 | Healthcare, Pharma/Bio
“The global dermatology drugs market is expected to grow from $66.8 billion in 2018 to $97.5 billion in 2022 at a CAGR of 9.9%” Dermatology Drugs Market Competitor Briefing 2019 – BCC Research BCC Research Dermatology Drugs Market Competitor Briefing 2019 EBSCO...
